Search results

Page results

• Their Majesties The King and Queen hear families' cancer stories at UCLH

  King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today. 

• Patient-initiated follow-up (PIFU) for women with endometrial cancer

  This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.

• Research at UCLH to tackle RSV infections in infants

  UCLH will play a vital role in a new respiratory virus study.

• Managing diabetes at Christmas - 2020

  Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.

• Why is it important to get your heart checked? Information for patients with mitochondrial disease

  This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.

• Bolstering world-class research in Women’s Health at UCLH

  UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.

• People with aphasia make significant improvements thanks to intensive programme at UCLH

  People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.

• ‘Before midnight' blood cells helped save life of UCLH patient

  Read more about a UCLH patient saved by special 'before midnight' transfusions.

• Plasma Exchange Service at NHNN

  Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.

• World-first genotyping test that could transform care for people with sickle cell

  The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.